
Invest wise with Expert advice
Get better recommendations Make better investments.
Get better recommendations Make better investments.
By continuing, I accept the Terms & Conditions and agree to receive communication on Whatsapp
According to a BSE notification dated September 28, it will be involved in the importing, warehousing, distribution, and exportation of pharmaceuticals.
The company has fixed the price band at Rs 133 to Rs 140 per equity share
Dr Reddy's was trying to expand its footprint in numerous developing categories such as nutraceuticals.
The price band for the offer, which closes on October 3, is Rs 133-140 per share.
A 51% stake in TCNS Clothing has been acquired by Aditya Birla Fashion Retail Ltd (ABFRL), making it a promoter of the women's clothing company.
The company intends to raise Rs 152 crore from the offer with fresh issue of equity shares and no element of offer for sale
The price band for this IPO is set at Rs 133-140 per share.
A full maintenance contract with a post-warranty cost of Rs 43.22 crore, including GST, is included in the contract.
Excluding deal-related amortization expenses, the Biogen Biosimilars deal could add 24% and 29% to Dr. Reddy’s FY24 revenue and profits on a pro-forma basis.
Valiant Laboratories is expected to make its debut on the BSE and NSE on October 9, 2023.